Stay updated on Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:40:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. The prior revision v3.4.2 was replaced.
    Difference
    0.1%
    Check dated 2026-03-11T17:39:56.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 and the prior funding-status notice (including the older revision v3.4.1) was removed. No study details, eligibility criteria, endpoints, or results information were modified.
    Difference
    0.4%
    Check dated 2026-02-11T09:22:28.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A site-wide government funding notice was added and a version update was applied (v3.4.1), replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:45:03.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Show glossary added to the page. The page metadata now includes 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older QC labels and references to 'No FEAR Act data' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:44:51.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.4 (replacing v3.3.3) in the footer. The study details, eligibility criteria, locations, and contacts remain unchanged.
    Difference
    0.1%
    Check dated 2026-01-14T01:21:31.000Z thumbnail image

Stay in the know with updates to Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.